Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Fair Value (Details Textual)

v3.21.1
Note 13 - Fair Value (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Mar. 31, 2021
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses $ 0  
Available-for-sale Securities, Amortized Cost Basis, Total   $ 2,200
Impaired Financing Receivable, Recorded Investment, Total 11,800 12,200
Impaired Financing Receivable, Related Allowance 1,800 1,900
Impaired Financing Receivable, Fair Value $ 10,000 $ 10,300